Literature DB >> 9075464

Visual imagery and perception in posttraumatic stress disorder. A positron emission tomographic investigation.

L M Shin1, S M Kosslyn, R J McNally, N M Alpert, W L Thompson, S L Rauch, M L Macklin, R K Pitman.   

Abstract

BACKGROUND: Relative regional cerebral blood flow (rCBF) changes were measured in Vietnam combat veterans with and without posttraumatic stress disorder (PTSD) during exposure to combat-related stimuli.
METHODS: Positron emission tomography was used to measure rCBF in 7 combat veterans with PTSD (PTSD group) and 7 healthy combat veterans (control group) who viewed and generated visual mental images of neutral, negative, and combat-related pictures.
RESULTS: Unlike control subjects, subjects with PTSD had increased rCBF in ventral anterior cingulate gyrus and right amygdala when generating mental images of combat-related pictures; when viewing combat pictures, subjects with PTSD showed decreased rCBF in Broca's area.
CONCLUSIONS: Results suggest that ventral anterior cingulate gyrus and right amygdala play a role in the response of combat veterans with PTSD to mental images of combat-related scenes. Reexperiencing phenomena of PTSD, which often involve emotional visual mental imagery, may be likewise associated with increased rCBF in these regions.

Entities:  

Mesh:

Year:  1997        PMID: 9075464     DOI: 10.1001/archpsyc.1997.01830150057010

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  80 in total

1.  The role of ventromedial prefrontal cortex in the recovery of extinguished fear.

Authors:  G J Quirk; G K Russo; J L Barron; K Lebron
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 2.  Neurocognitive functioning in posttraumatic stress disorder.

Authors:  Michael David Horner; Mark B Hamner
Journal:  Neuropsychol Rev       Date:  2002-03       Impact factor: 7.444

3.  Functional neuroanatomy of emotions: a meta-analysis.

Authors:  Fionnuala C Murphy; Ian Nimmo-Smith; Andrew D Lawrence
Journal:  Cogn Affect Behav Neurosci       Date:  2003-09       Impact factor: 3.282

Review 4.  Neuroimaging studies in post-traumatic stress disorder.

Authors:  J Douglas Bremner
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

5.  Alterations in the neural circuitry for emotion and attention associated with posttraumatic stress symptomatology.

Authors:  Jasmeet Pannu Hayes; Kevin S Labar; Christopher M Petty; Gregory McCarthy; Rajendra A Morey
Journal:  Psychiatry Res       Date:  2009-02-23       Impact factor: 3.222

6.  Regional homogeneity and resting state functional connectivity: associations with exposure to early life stress.

Authors:  Noah S Philip; Yuliya I Kuras; Thomas R Valentine; Lawrence H Sweet; Audrey R Tyrka; Lawrence H Price; Linda L Carpenter
Journal:  Psychiatry Res       Date:  2013-10-03       Impact factor: 3.222

Review 7.  Stress and brain atrophy.

Authors:  J Douglas Bremner
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-10       Impact factor: 4.388

Review 8.  Neuroimaging in posttraumatic stress disorder and other stress-related disorders.

Authors:  J Douglas Bremner
Journal:  Neuroimaging Clin N Am       Date:  2007-11       Impact factor: 2.264

9.  Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder.

Authors:  Christopher S Monk; Eva H Telzer; Karin Mogg; Brendan P Bradley; Xiaoqin Mai; Hugo M C Louro; Gang Chen; Erin B McClure-Tone; Monique Ernst; Daniel S Pine
Journal:  Arch Gen Psychiatry       Date:  2008-05

10.  Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder.

Authors:  Paulo Sergio Boggio; Martha Rocha; Maira Okada Oliveira; Shirley Fecteau; Roni B Cohen; Camila Campanhã; Eduardo Ferreira-Santos; Alexandrina Meleiro; Felipe Corchs; Soroush Zaghi; Alvaro Pascual-Leone; Felipe Fregni
Journal:  J Clin Psychiatry       Date:  2009-12-29       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.